摘要 |
<p>This invention pertains to transdermal administration devices, and more particularly, to transdermal administration devices that contain: (a) a pharmaceutical composition for the systemic administration of a NSAID; (b) a backing layer; and, (c) a release liner; wherein said pharmaceutical composition includes at least one component that enhances percutaneous permeation selected from: (i) fatty alcohols (C4-C30); (ii) mono, di or triglyceryl fatty acid esters (C4-C30); and, (iii) fatty acid esters (C4-C30); and a pressure sensitive acrylic adhesive matrix formed by a copolymer with polar functional groups in which the NSAID is incorporated.</p> |